Dániel Aradi

6.7k total citations
70 papers, 1.6k citations indexed

About

Dániel Aradi is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Dániel Aradi has authored 70 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Cardiology and Cardiovascular Medicine, 42 papers in Surgery and 16 papers in Internal Medicine. Recurrent topics in Dániel Aradi's work include Antiplatelet Therapy and Cardiovascular Diseases (53 papers), Acute Myocardial Infarction Research (39 papers) and Coronary Interventions and Diagnostics (33 papers). Dániel Aradi is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (53 papers), Acute Myocardial Infarction Research (39 papers) and Coronary Interventions and Diagnostics (33 papers). Dániel Aradi collaborates with scholars based in Hungary, Germany and United States. Dániel Aradi's co-authors include András Komócsi, András Vorobcsuk, Dirk Sibbing, Iván Horváth, Laurent Bonello, Orsolya Rideg, Tamás Magyarlaki, Dietmar Trenk, Margit Tökés‐Füzesi and Attila Kónyi and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Dániel Aradi

68 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dániel Aradi Hungary 22 1.4k 748 464 155 104 70 1.6k
Ioanna Xanthopoulou Greece 23 1.7k 1.2× 987 1.3× 453 1.0× 260 1.7× 78 0.8× 77 2.0k
Anne Bellemain-Appaix France 18 1.2k 0.8× 629 0.8× 276 0.6× 131 0.8× 112 1.1× 33 1.5k
Cristina Giglioli Italy 20 1.4k 0.9× 634 0.8× 318 0.7× 169 1.1× 145 1.4× 54 1.6k
Laurent Payot France 11 1.4k 1.0× 717 1.0× 373 0.8× 271 1.7× 146 1.4× 27 1.8k
George Kassimis Greece 19 1.3k 0.9× 853 1.1× 210 0.5× 208 1.3× 57 0.5× 110 1.6k
Bonnie L. Hiatt United States 6 1.3k 0.9× 687 0.9× 382 0.8× 64 0.4× 93 0.9× 9 1.4k
Martin M. Zenni United States 20 1.3k 0.9× 749 1.0× 369 0.8× 77 0.5× 49 0.5× 41 1.5k
Jan A.S. Van der Heyden Netherlands 14 988 0.7× 473 0.6× 226 0.5× 92 0.6× 67 0.6× 30 1.1k
Róbert Gábor Kiss Hungary 17 1.2k 0.9× 443 0.6× 357 0.8× 120 0.8× 96 0.9× 93 1.7k
Drew A. Purdy United States 3 1.3k 0.9× 661 0.9× 411 0.9× 38 0.2× 83 0.8× 4 1.4k

Countries citing papers authored by Dániel Aradi

Since Specialization
Citations

This map shows the geographic impact of Dániel Aradi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dániel Aradi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dániel Aradi more than expected).

Fields of papers citing papers by Dániel Aradi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dániel Aradi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dániel Aradi. The network helps show where Dániel Aradi may publish in the future.

Co-authorship network of co-authors of Dániel Aradi

This figure shows the co-authorship network connecting the top 25 collaborators of Dániel Aradi. A scholar is included among the top collaborators of Dániel Aradi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dániel Aradi. Dániel Aradi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kiss, Zoltán, György Rokszin, Ibolya Fábián, et al.. (2023). Mortality on DOACs Versus on Vitamin K Antagonists in Atrial Fibrillation: Analysis of the Hungarian Health Insurance Fund Database. Clinical Therapeutics. 45(4). 333–346. 1 indexed citations
2.
Kosztin, Annamária, Máté Vámos, Dániel Aradi, et al.. (2017). De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis. Heart Failure Reviews. 23(1). 15–26. 34 indexed citations
3.
Aradi, Dániel, et al.. (2017). Clinical outcomes in patients treated for coronary in-stent restenosis with drug-eluting balloons: Impact of high platelet reactivity. PLoS ONE. 12(12). e0188493–e0188493. 4 indexed citations
4.
Winter, Max‐Paul, Marek Koziński, Jacek Kubica, Dániel Aradi, & Jolanta M. Siller‐Matula. (2015). Personalized antiplatelet therapy with P2Y 12 receptor inhibitors: benefits and pitfalls. Advances in Interventional Cardiology. 4(4). 259–280. 42 indexed citations
5.
Aradi, Dániel, Dirk Sibbing, & Lisa Groß. (2015). Prevention of cardiovascular events with antiplatelet treatment: does time of intake matter for aspirin and ADP receptor blockers?. Thrombosis and Haemostasis. 115(1). 3–6. 8 indexed citations
6.
Faluközy, József, et al.. (2015). Eptifibatide-induced thrombocytopenia leading to acute stent thrombosis. Journal of Thrombosis and Thrombolysis. 41(3). 522–524. 5 indexed citations
7.
Aradi, Dániel, Béla Merkely, & András Komócsi. (2015). Platelet Reactivity: Is There a Role to Switch?. Progress in Cardiovascular Diseases. 58(3). 278–284. 4 indexed citations
8.
Aradi, Dániel, András Vorobcsuk, Attila Kónyi, et al.. (2014). Optimizing P2Y12 Receptor Inhibition in Patients With Acute Coronary Syndrome on the Basis of Platelet Function Testing. Journal of the American College of Cardiology. 63(11). 1061–1070. 62 indexed citations
9.
Vorobcsuk, András, et al.. (2014). Apixaban and risk of myocardial infarction: meta-analysis of randomized controlled trials. Journal of Thrombosis and Thrombolysis. 40(1). 1–11. 7 indexed citations
10.
Aradi, Dániel, et al.. (2013). OPTIMIZING P2Y12–RECEPTOR INHIBITION IN ACUTE CORONARY SYNDROME PATIENTS AFTER PCI USING PLATELET FUNCTION TESTING: IMPACT OF PRASUGREL VERSUS HIGH–DOSE CLOPIDOGREL. Journal of the American College of Cardiology. 61(10). E1922–E1922. 4 indexed citations
11.
Serebruany, Victor L., Alex Pokov, Dániel Aradi, et al.. (2013). Effect of Aliskiren and Valsartan Combination Versus Aliskiren Monotherapy on Hemostatic Biomarkers in Hypertensive Diabetics. American Journal of Therapeutics. 21(6). 482–490. 1 indexed citations
12.
Bonello, Laurent, Marc Laine, Karine Baumstarck, et al.. (2013). A randomized trial of platelet reactivity monitoring-adjusted clopidogrel therapy versus prasugrel therapy to reduce high on-treatment platelet reactivity. International Journal of Cardiology. 168(4). 4244–4248. 9 indexed citations
13.
Aradi, Dániel, András Komócsi, Matthew J. Price, et al.. (2012). TCT-747 Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: Systematic review and meta-analysis. Journal of the American College of Cardiology. 60(17). B218–B218.
14.
Aradi, Dániel, et al.. (2012). TCT-741 Impact of clinical presentation on platelet inhibition by ticagrelor compared to clopidogrel: insights from a single-center cohort of the PLATO trial. Journal of the American College of Cardiology. 60(17). B216–B216. 1 indexed citations
15.
Komócsi, András, András Vorobcsuk, Victor L. Serebruany, & Dániel Aradi. (2012). Impact of clopidogrel and potent P2Y12-inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention. Thrombosis and Haemostasis. 109(1). 93–101. 35 indexed citations
16.
Aradi, Dániel & András Komócsi. (2011). Platelet function monitoring in patients on clopidogrel: What should we learn from GRAVITAS?. Platelets. 23(3). 167–176. 5 indexed citations
17.
Aradi, Dániel, Orsolya Rideg, András Vorobcsuk, et al.. (2011). Justification of 150 mg clopidogrel in patients with high on‐clopidogrel platelet reactivity. European Journal of Clinical Investigation. 42(4). 384–392. 33 indexed citations
18.
Kuliczkowski, Wiktor, et al.. (2011). Inter-patient variability and impact of proton pump inhibitors on platelet reactivity after prasugrel. Thrombosis and Haemostasis. 107(2). 338–345. 22 indexed citations
19.
Aradi, Dániel, András Komócsi, András Vorobcsuk, et al.. (2010). Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: Systematic review and meta-analysis. American Heart Journal. 160(3). 543–551. 164 indexed citations
20.
Malinin, Alex I., Dániel Aradi, Wiktor Kuliczkowski, et al.. (2010). The in vitro effects of niacin on platelet biomarkers in human volunteers. Thrombosis and Haemostasis. 104(8). 311–317. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ioanna Xanthopoulou Breakdown of academic impact, for papers by Anne Bellemain-Appaix Breakdown of academic impact, for papers by Cristina Giglioli Breakdown of academic impact, for papers by Laurent Payot Breakdown of academic impact, for papers by George Kassimis Breakdown of academic impact, for papers by Bonnie L. Hiatt Breakdown of academic impact, for papers by Martin M. Zenni Breakdown of academic impact, for papers by Jan A.S. Van der Heyden Breakdown of academic impact, for papers by Róbert Gábor Kiss Breakdown of academic impact, for papers by Drew A. Purdy
Rankless by CCL
2026